Zevra Therapeutics (ZVRA) Net Equity Issued and Repurchased (2015 - 2026)
Zevra Therapeutics' Net Equity Issued and Repurchased was $1.58 million in Q3 2026, down 75.8% from $6.53 million a year earlier but up 263.2% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zevra Therapeutics' Net Equity Issued and Repurchased was $14.48 million through Sep 30, 2026, up 35.5% year-over-year; for FY2025, it was $12.44 million, down 81.5% from FY2024.
- Net Equity Issued and Repurchased shows a four-year compound annual growth rate of -42.5% (FY2021 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $67.26 million in FY2024, $2.88 million in FY2023, -$4.4 million in FY2022 and $114.04 million in FY2021.
- Quarterly Net Equity Issued and Repurchased has moved between -$4.72 million (Q1 2022) and $64.77 million (Q3 2024) over five years.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in four of the last eight quarters, with growth averaging 68.8%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2026 (growth of 401.4%); the worst was Q3 2025 (a decline of 89.9%).
- Per Business Quant data, ZVRA's Net Equity Issued and Repurchased in the three quarters before Q3 2026 was $435,000 (Q2 2026), $9.92 million (Q1 2026) and $2.55 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 1.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.58 Mn |
| Jun 30, 2026 | 435,000.00 |
| Mar 31, 2026 | 9.92 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 796,000.00 |
| Sep 30, 2024 | 64.77 Mn |
| Jun 30, 2024 | 480,000.00 |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 6.11 Mn |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | -3.45 Mn |
| Dec 31, 2022 | 436.27 Mn |
| Jun 30, 2022 | 216,000.00 |
| Mar 31, 2022 | -4.72 Mn |
| Dec 31, 2021 | -2.81 Mn |
| Sep 30, 2021 | 77.76 Mn |
API Access
Zevra Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();